Dan Leonard
Stock Analyst at UBS
(2.44)
# 2,386
Out of 4,873 analysts
289
Total ratings
53.12%
Success rate
-6.22%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Upgrades: Buy | $1,530 → $1,350 | $1,185.18 | +13.91% | 9 | May 20, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $14 → $12 | $10.89 | +10.19% | 5 | May 13, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $95 → $70 | $50.01 | +39.97% | 11 | May 9, 2025 | |
| BRKR Bruker | Maintains: Neutral | $57 → $45 | $39.66 | +13.46% | 11 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $255 → $185 | $158.58 | +16.66% | 14 | May 7, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $355 → $310 | $237.91 | +30.30% | 20 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $355 → $310 | $238.95 | +29.73% | 20 | May 2, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $70 | $49.99 | +40.03% | 9 | May 1, 2025 | |
| RVTY Revvity | Upgrades: Buy | $145 → $115 | $96.39 | +19.31% | 2 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $715 → $500 | $404.37 | +23.65% | 15 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $240 | $197.47 | +21.54% | 17 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $13.46 | +85.74% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $148.40 | +24.66% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $7.30 | +23.29% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $420 → $350 | $315.28 | +11.01% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $16 | $10.69 | +49.67% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $19.55 | +79.03% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $117.64 | +27.51% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $91.52 | +118.53% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $2.23 | +393.27% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $171.87 | -59.27% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $90 | $51.17 | +75.88% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $10.65 | -34.27% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $346.80 | -0.52% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $148.54 | +75.04% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $179.90 | -19.40% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $64.83 | +38.82% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $47.23 | +34.77% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $262.53 | +29.51% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $24.59 | -2.40% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $5.05 | +593.07% | 12 | Aug 14, 2019 |
Mettler-Toledo International
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,185.18
Upside: +13.91%
10x Genomics
May 13, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $10.89
Upside: +10.19%
Bio-Techne
May 9, 2025
Maintains: Buy
Price Target: $95 → $70
Current: $50.01
Upside: +39.97%
Bruker
May 8, 2025
Maintains: Neutral
Price Target: $57 → $45
Current: $39.66
Upside: +13.46%
IQVIA Holdings
May 7, 2025
Maintains: Buy
Price Target: $255 → $185
Current: $158.58
Upside: +16.66%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $237.91
Upside: +30.30%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $238.95
Upside: +29.73%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $49.99
Upside: +40.03%
Revvity
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $96.39
Upside: +19.31%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $715 → $500
Current: $404.37
Upside: +23.65%
Apr 23, 2025
Maintains: Buy
Price Target: $275 → $240
Current: $197.47
Upside: +21.54%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $13.46
Upside: +85.74%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $148.40
Upside: +24.66%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $7.30
Upside: +23.29%
Sep 27, 2024
Downgrades: Neutral
Price Target: $420 → $350
Current: $315.28
Upside: +11.01%
Sep 27, 2024
Upgrades: Buy
Price Target: $16
Current: $10.69
Upside: +49.67%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $19.55
Upside: +79.03%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $117.64
Upside: +27.51%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $91.52
Upside: +118.53%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $2.23
Upside: +393.27%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $171.87
Upside: -59.27%
Aug 2, 2023
Maintains: Neutral
Price Target: $75 → $90
Current: $51.17
Upside: +75.88%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $10.65
Upside: -34.27%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $346.80
Upside: -0.52%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $148.54
Upside: +75.04%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $179.90
Upside: -19.40%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $64.83
Upside: +38.82%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $47.23
Upside: +34.77%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $262.53
Upside: +29.51%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $24.59
Upside: -2.40%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $5.05
Upside: +593.07%